• SENSEX 80,737.51
    -636.24 (--0.78%)
  • BANKNIFTY 55,599.95
    -303.45 (--0.54%)
  • Yes Bank
    20.77 16.02(%)
  • Vodafone Idea
    6.74 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • TCS
    3,399.40 3,060.25(%)
  • Larsen & Toubro
    3,617.00 2,967.65(%)
  • Eternal Ltd
    236.80 146.85(%)
  • Zinka Logistics
    451.35 548.00(%)
  • M & M
    3,065.15 3,276.30(%)
  • HDFC Bank
    1,920.00 1,452.85(%)
  • Garden Reach Sh.
    3,188.75 3,143.00(%)
  • Cochin Shipyard
    2,049.70 2,977.10(%)
  • Reliance Industr
    1,403.00 1,115.55(%)
  • Suzlon Energy
    67.95 45.13(%)
  • Kotak Mah. Bank
    2,033.40 1,602.20(%)
  • Brainbees Solut.
    393.00 734.25(%)
  • Infosys
    1,535.35 1,307.10(%)
  • ICICI Bank
    1,431.75 1,051.50(%)
  • Bharti Airtel
    1,831.75 1,224.50(%)
  • Reliance Power
    58.50 23.26(%)
  • Axis Bank
    1,175.00 934.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sun Pharma Advanced Research Company Ltd Miscellaneous

  • Sun Pharma
  • BSE Code : 27675.0
  • ISIN : INE232I01014
195.18 -3 (-1.69%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    192.50

  • Today’s High

    199.49

  • Open

    199.45

  • Perv Close

    198.54

  • 52W Low

    109.30

  • 52W High

    258.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    6,334.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.80

  • Debt-Equity Ratio

    -1.69

  • AGM Date

    03-Jun-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    6,334.01

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    32.45

  • BV (₹)

    -6.80

  • Sales( ₹ in Cr.)

    71.77

  • NP (in Cr.)

    -345.22

  • NP Var(%)

    11.0

  • Div%

    0.0

  • CPS (₹)

    -10.30

  • EPS (₹)

    -10.60

  • Traded Value (₹ in Lakhs)

    6,440.13

  • 52 Week High

    258.00

  • 52 Week Low

    109.30

  • Price BSE

    198.0

  • Price NSE

    199.00

  • Market Capital( in Cr.)

    6,440.13

  • P/C Ratio

    -19.20

  • P/E Ratio

    -18.60

  • Price Vs.BV

    -10.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 75.55 238.78 137.25 252.96 76.81 182.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.55 238.78 137.25 252.96 76.81 182.87
Other Income 29.47 10.88 6.84 5.41 9.76 13.51
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 105.02 249.66 144.09 258.37 86.57 196.38
EXPENDITURE :            
Raw Materials 0.00 0.00 18.27 18.18 23.93 12.53
Power and Fuel Cost 6.14 5.75 4.62 4.60 5.14 5.08
Employee Cost 118.53 107.00 98.31 91.59 93.09 81.06
Other Manufacturing Expenses 55.37 45.51 17.06 17.93 10.59 157.99
Selling and Administration Expenses 292.27 289.71 183.33 252.17 247.28 68.70
Miscellaneous Expenses 7.03 4.87 2.41 3.48 6.81 8.80
Employee Benefit Expenses 118.53 107.00 98.31 91.59 93.09 81.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 479.34 452.84 324.00 387.94 386.83 334.16
Operating Profit -374.32 -203.18 -179.90 -129.57 -300.25 -137.79
Interest 1.66 7.63 13.33 10.65 2.67 0.09
Gross Profit -375.98 -210.81 -193.23 -140.22 -302.92 -137.88
Depreciation 12.13 11.77 10.16 10.92 9.48 7.55
Profit Before Tax -388.11 -222.58 -203.39 -151.14 -312.40 -145.43
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Extraordinary Items 0.58 -0.11 4.89 0.26 6.27 5.18
Adjusted Net Profit -388.69 -222.47 -208.29 -151.40 -318.67 -150.61
Adjustment below Net Profit 0.19 1.35 1.70 1.53 -2.47 -18.06
P & L Balance brought forward -1,591.81 -1,370.58 -1,168.88 -1,019.27 -704.40 -540.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27 -704.40
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -11.96 -6.86 -7.48 -5.77 -11.92 0.00
Earnings Per Share(Adj)-Unit Curr -11.96 -6.86 -7.48 -5.77 -11.92 0.00
Book Value 3.85 15.80 -7.47 -6.42 -0.71 11.30
Book Value(Adj)-Unit Curr 3.85 15.80 -7.47 -6.42 -0.71 11.30

Shareholding Pattern

  • Promoter Group

    65.67%

  • Public Share Holding

    34.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 147,674,210 45.51 147,673,010 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 65,440,885 20.17 65,440,885 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 213,115,095 65.67 213,113,895 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 668 0.00 668 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 650 0.00 566 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,697,813 1.45 4,697,813 30
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 1,200 0.00 0 1
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,279,952 1.01 3,279,852 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 388,262 0.12 388,262 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,368,545 2.58 8,367,161 54
2] Non Institution
Bodies Corporate 23,646,320 7.29 23,634,586 761
Clearing Members 9,054 0.00 9,054 11
Directors of their Relatives 722,810 0.22 722,810 11
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 9,600 0.00 9,600 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,177,908 0.67 2,168,204 2,004
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,556,131 0.79 2,556,131 3,002
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,421,596 4.14 13,421,596 18
Individuals holding nominal share capital up to Rs. 1 lakh 48,194,761 14.85 47,662,953 136,878
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 7,048 0.00 7,048 5
Others 11,352,389 3.50 11,352,389 4
Sub Total 103,037,948 31.75 102,484,702 142,796
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 324,521,588 100.00 323,965,758 142,864

Company Background

Sun Pharma Advanced Research Company LtdMiscellaneous

  • Sun Pharma Advanced Research Company Ltd
  • BSE Code : 27675.0
  • ISIN : INE232I01014

  • Incorporation Year

    2006

  • Registered Office

    Sun Pharma Advanced Res Centre
    Akota Road Akota, Vadodara,
    Gujarat-390020

  • Telephone

    91-265-2330815/2339257

  • FAX

    91-265-2354897

  • Chairman

    Dilip S Shanghvi

  • Managing Director

  • Company Secretary

    Kajal Damania.

  • Auditor

    S R B C & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sun Pharma Advanced Research Company Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SPARC 195.60 105.01 75.55 -18.38 0.00
Abbott India 31,061.15 6,097.18 5,848.91 46.66 44.71
Astrazeneca Phar 9,334.25 1,330.33 1,295.53 201.60 33.26
P & G Health Ltd 5,742.35 1,166.89 1,151.26 37.95 39.76
Glaxosmi. Pharma 3,223.65 3,530.73 3,407.25 59.42 44.44
Cipla 1,472.80 17,645.00 16,574.34 23.06 20.10
Amrutanjan Healt 730.95 437.58 421.23 41.58 20.84
Fermenta Biotec. 324.00 315.24 307.09 14.11 4.10
Guj. Themis Bio. 306.40 174.19 169.82 68.39 44.82
Bliss GVS Pharma 133.00 638.96 605.46 20.31 11.19
Ambalal Sarabhai 37.52 11.70 3.81 34.74 1.92